a b s t r a c t
Different lines of evidence support BDNF as a candidate gene in mood and anxiety modulation. More recently, the Met allele of the BDNF Val66Met polymorphism has been implicated in anxiety in animal models and anxiety-traits in humans. The aim of this study is to evaluate the a priori hypothesis that the association between anxiety disorders and Val66Met polymorphism at the BDNF gene would be replicated in a community sample of children and adolescents. 240 subjects from a total sample of 2457 children and adolescents aged 10-17 years from the public schools in the catchment area of the primary care unit of a university hospital participated in this case-control study and were assessed for psychopathology using the K-SADS-PL. A sample of saliva was collected for DNA analysis of Val66Met polymorphism. BDNF was the single gene evaluated in this sample. We found a significant association between carrying one copy of the Met allele and higher chance of anxiety disorders in children and adolescents. The association remained positive even after the adjustment for potential confounders (228 subjects; OR = 3.53 (CI95% 1.77-7.06; p < 0.001)). Our results support the a priori hypothesis of an association between anxiety and the polymorphism Val66Met. To our knowledge, this is the first study documenting a potential role of this polymorphism in a community sample of anxious children and adolescents.
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Anxiety disorders are prevalent in childhood and adolescence and are associated with impairments in academic, social and family functioning, as well as related to the persistence of psychopathology in adulthood [2] . Family history is one of the best-established risk factors for anxiety disorders, with heritability estimates ranging from 20 to 40% [12] . Brain derived neurotrophic factor (BDNF) plays an important role in neuronal differentiation during brain development, as well as in synaptic plasticity and neuronal survival in the adult brain [37] . A common variant of the BDNF gene in humans, consisting of a single nucleotide polymorphism (SNP, rs 6265) in the prodomain region, which produces a valine-to-methionine sub-stitution at codon 66 (Val66Met), has been explored with some promising results in association to neuropsychiatric disorders [21] . Animal models showed that the Met allele of the BDNF genotype is associated with a reduced BDNF secretion and higher anxious behaviors [5] . If the Met allele is associated with anxiety disorders or not is a matter of intense discussion in literature [13, 17, 35, 40] . Some studies have also implicated the Val allele of the BDNF genotype in vulnerability for anxiety [10, 17] . A recent study with functional neuroimaging in adolescents showed that Met-carriers had greater neural responses for emotional faces, suggesting that the Met allele might affect important neural correlates for anxiety and depression [19] .
The primary objective of this investigation was to examine the role of Val66Met polymorphism in anxiety disorders in childhood and adolescence. Our a priori hypothesis was that the Met allele of that BDNF genotype would be a risk factor for anxiety disorders in this group. To our knowledge this is the first investigation examining the impact of Val66Met in a community sample of children and adolescents evaluated with stringent criteria for anxiety disorders. Cases and controls were selected from a larger community sample of 2457 children and adolescents (10-17 years) that participated in a cross-sectional anxiety disorder study [32] . All subjects (cases and controls) came from the same community sample in the south of Brazil. A recent study with 48 ancestry informative markers showed that individuals from southern Brazil present an almost exclusively European ancestry [33] . Skin color was assessed by observation during the clinical interview. Socio-economic status was evaluated using an official index of the Brazilian Institute of Geography and Statistics. All parents provided written informed consent for participating in the study. This study is in compliance with the Declaration of Helsinki and was approved by the Research and Ethics Committee of HCPA (07-595).
The K-SADS-PL (Schedule for Affective Disorder and Schizophrenia for School-Age Children -Present and Lifetime Version) is a semi-structured interview based on the DSM-IV criteria that [14] was administered to the mother/father followed by a direct interview with all the child/adolescent. Best-estimate diagnoses were determined after reviewing generated diagnoses, symptoms and impairment level by clinicians with experience in Child Psychiatry (total number of interviewers = 6, kappa = 0.93 across anxiety disorders).
Children diagnosed with social anxiety disorder, generalized anxiety disorder, separation anxiety disorder or panic disorderaccording to the K-SADS-PL -were selected as cases. Subjects without any anxiety disorder except for specific phobia were selected as controls. Individuals with: (1) significant organic illness; (2) history of bipolar disorder, pervasive developmental disorder or any psychotic disorder; (3) history of alcohol or drugs dependence or abuse; and (4) clinical suspicious of mental retardation were excluded from this study. Table 1 outlines the rates of disorders by group, comorbid conditions and gender.
Additionally, subjects were evaluated for the anxiety-related traits harm-avoidance (HA) and behavior inhibition (BI) using self-report instruments. HA was assessed with the Cloninger's Temperament and Character Inventory [6] . This instrument has already been used in adolescents [20] . HA is described as a heritable tendency to inhibit or stop behaviors in response to signals of aversive stimuli in order to avoid punishment. The Self-Report Scale of Behavioral Inhibition -Retrospective Version [30] was used to assess childhood BI, a temperamental risk factor for panic and phobic anxiety disorders [36] .
DNA was extracted from biological samples of saliva using the DNA 2006 Oragene ® Kit (Laboratory Protocol for Manual Purification of DNA from 4.0 mL of Oragene ® DNA saliva). Genotyping was based on the technique described by Ribasés et al. [31] . The researchers involved in genotyping were blind for the phenotypes, and identical procedures were used for genotyping all cases and controls.
Data are presented as mean ± standard deviation, count and percentage (%). For the analysis, we excluded the four Met/Met individuals, considering the small sample size as suggested by Kaufman et al. [15] . Analysis was carried on using anxiety disorders as a group. Bivariate analysis between cases and controls were made with Fisher's Exact test, Pearson's Chi-square and independent Student's t-test. We ran a logistic regression model controlling for confounders using anxiety disorders group as dependent variable. A linear regression model was used to analyze anxiety-related traits (HA and BI). All variables with a p-value less than 0.20 plus age, gender and skin color were included in the model. Additional analysis was run using as a control group only those subjects without any psychopathology (n = 61).
Tests for deviation from Hardy-Weinberg equilibrium were conducted with the 2 test for goodness of fit. Statistical analysis was performed using the software SPSS version 14.0 and PEPI v. 4.0 for DOS. The level of significance used was ˛ = 0.05. Considering a Met allele frequency of 20%, we have a power of 84% to detect OR higher than 2.5. It is important to note that no other polymorphism or gene was assessed in this sample thus minimizing chances of Error type I due to multiple testing.
From the 2457 children that accepted to participate in the crosssectional study, 240 attended diagnostic evaluation and had their saliva collected for DNA extraction for this case-control study. Only unrelated children were included in the analysis (n = 234). Three cases and three controls were excluded due to mental retardation. Hence the final sample included 131 cases and 97 controls. From cases of anxiety disorders, 93 (71%) were diagnosed as having Generalized Anxiety Disorder, 55 (42%) with social anxiety disorder, 46 (35.1%) with separation anxiety disorder and 9 (6.9%) with panic disorder. Seventy-five (57.3%) had one anxiety disorder only, 41 (31.3%) had two anxiety disorders and 15 (1.5%) had three or four anxiety disorders. Family history of anxiety was positive in 57 (67.9%) patients and 27 (32.1%) controls (OR 1.88, CI95% 1.07-3.31, p = 0.035).
Demographic data, psychiatric comorbidity and genotype comparisons between cases and controls are depicted in Table 1 . The genotypic frequencies observed are very similar to other studies in Caucasian populations [10] . Logistic regression shows that carrying one copy of the Met allele confers increased chance of having an anxiety disorder during childhood and adolescence, OR = 3.53 (CI95% 1.77-7.06; p < 0.001) ( Table 2 ). Secondary analysis considering as the control group exclusively subjects with no major psychiatric disorder (n = 61) confirms the difference regarding carrying the Met allele described between anxious patients and non-anxious controls, OR = 3.73 (B = 1.32, Wald = 9.76, CI95% 1.63-8.54; p = 0.002; logistic regression controlled for gender, age, skin color and presence of specific phobia). Additionally, we run an analysis including the Met/Met individuals in a dominant model and we still have a positive association (cases 51/80 vs. controls 21/76, Fisher's test, p = 0.0062).
Out of the final sample of 228 subjects, 102 were evaluated for harm-avoidance (HA) and 104 for behavior inhibition (BI). In our study, we observed that Val/Met genotype was an independent risk factor for anxiety disorders during childhood and adolescence. Our results are in agreement with findings from animal models [5] and association studies in adulthood that have reported an association between BDNF and anxiety modulation [9, 11, 25] . Taken together all these results support the hypothesis that BDNF has neurobiological features that makes it a candidate gene in regulation of anxiety.
At least two possible explanations might account for our results. First, BDNF may be associated with anxiety by interfering in fear processing orchestrated by mesial temporal lobe structures, including amygdala and hippocampus. Several evidences suggest that hippocampus and amygdala play a major role in the cerebral pathways linked to anxiety [1] . According with previous studies [3, 26, 28] , individuals heterozygous for the 66Met BDNF allele have smaller hippocampus volume and worse hippocampal dependent memory functions. Second, it is possible that BDNF polymorphism interfere in serotonin-mediated pathways leading to anxiety. Decreased BDNF expression has been described in depressed adolescents exposed to adverse events [4] -and there is a known relation between traumatic events, anxiety and depression, with some theoretical common causal pathways. Kaufman et al. [15] showed an interaction between the BDNF genotype (Met allele), the gene of the serotonin transporter and maltreatment history in predicting depression in a sample of children, which was not replicated by recent studies [27] . Moreover, chronic antidepressant treatment with selective serotonin reuptake inhibitors (which are also effective in the treatment of anxiety) increases the expression of BDNF and may enhance its localization at synaptic level [4] .
In our study we found an association between Val/Met genotype and between the dominant model and anxiety disorders, but not with anxiety-related traits (harm-avoidance and behavior inhibition) in children and adolescents as it was expected. It can be suggested that the association between the Met allele and anxiety is dependent on the presence of symptoms severe enough to cause impairment and to reach the diagnostic status. On the other hand, we could have not found an association between anxiety traits and the Val/Met genotype because these traits, differently from the diagnostic evaluation, were assessed by self-report instruments that could not be completely understood by our subjects. It is also possible that we did not have power to detect an association due to the smaller sample size included in the BI and HA measures.
We analyzed anxiety disorders as a group based on the significant comorbidity and overlap between anxiety diagnosis in children and adolescents [16, 29] . Considering the diathesis-stress theory, anxiety may be expressed according to stressors during the life course [22, 39] . The analysis considering anxiety as a group is in agreement to previous studies that have shown that the heritability of anxiety is not disorder specific [36] . Most studies have shown moderate convergence between children's self-report measures and anxiety diagnoses but demonstrated poorer agreement at the level of specific anxiety disorders [34] . Moreover randomized clinical trials for anxiety disorders in childhood also evaluate anxiety disorder as a group [38] . This approach, even not considering the validity of different diagnosis of anxiety disorders poor, takes into account a common etiology and treatment response [18] . Besides this, we excluded specific phobia from the anxiety group because of its higher frequency and higher rates of remission without treatment [7] . Moreover it has a different factor of heritability as compared to other anxiety disorders [8] .
Yet our study presents some limitations. The moderate sample size was due to the origin of the sample -community sample -subjects were not looking for treatment, and the participation in the study required a hospital visit both time and cost demanding. Additionally, the risk for biases related to ethnic stratification cannot be excluded and no genomic control was performed in our study. Therefore our findings could have been biased by hidden genetic heterogeneity that can be present in the Brazilian population of European ancestry. This confounding factor was minimized through the selection of a community school sample -all the cases and controls came from exactly the same population and we controlled the analysis for skin color. Another limitation is that we did not have power to test for gender and gene interaction.
This study is innovative in combining three aspects: (1) a community sample, (2) a sample comprised by children and adolescents and (3) a stringent psychiatric evaluation for anxiety disorders. Previous studies had investigated the effect of BDNF gene in children and adolescents, but did not evaluate psychiatric disorder. One evaluated a sample with "anxious depression symptoms" [24] and the other one characterized adolescents with internalizing disorders [23] . Studying a community sample avoids the potential selection biases of clinical samples, such as the restriction to more severe cases of patients in treatment. In our study, we included as cases subjects that have never been previously diagnosed as having anxiety disorders. Our cases included those with less severe disorder and those whose parents' hesitate looking for psychiatric treatment. Consequently, our findings can represent a broader concept of anxiety disorders, which is not restricted to severe cases.
Besides this, both cases and controls came from the same population, with the same epidemiological background.
Studying psychiatric symptoms in children brings the opportunity of evaluating complex behavior early in the development, possibly contributing to the understanding of psychopathological processes. Our findings from a community sample of children and adolescents assessed through out a detailed clinical evaluation add new relevant data to the international literature, since genetic findings on this polymorphism in childhood are scarce. Our study reinforces the hypothesis that BDNF can be related to the development of early onset of anxiety disorders. Additional studies to confirm our findings are necessary.
